Rituximab in life threatening antisynthetase syndrome

This case study reports a patient with severe interstitial pneumonitis, mild polyarthritis and polymyositis, accompanied by the presence of anti-Jo-1 antibodies diagnosed as antisynthetase syndrome. The concurrence of anti-Jo-1 with anti-Ro/SSA antibodies leads to a more severe form of interstitial...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Rheumatology international 2009-10, Vol.29 (12), p.1499-1502
Hauptverfasser:	Vandenbroucke, E., Grutters, J. C., Altenburg, J., Boersma, W. G., ter Borg, E. J., van den Bosch, J. M. M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Antinuclear - blood Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antirheumatic Agents - therapeutic use Arthritis - blood Arthritis - drug therapy Arthritis - immunology Case Report Dose-Response Relationship, Drug Humans Lung Diseases, Interstitial - blood Lung Diseases, Interstitial - drug therapy Lung Diseases, Interstitial - immunology Male Medicine Medicine & Public Health Middle Aged Polymyositis - blood Polymyositis - drug therapy Polymyositis - immunology Receptors, Interleukin-2 - blood Rheumatology Rituximab Syndrome Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!